In contrast, conflicting data have been reported for the correlation between DR4/DR5 expression and patient survival for renal cell carcinoma [311] and hepatocellular carcinoma (HCC) [304]. This evidence concerns the gene TNFRSF10B and hepatocellular carcinoma.